» Articles » PMID: 12224523

Anthrax Vaccines

Overview
Date 2002 Sep 13
PMID 12224523
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

The only impetus for the development of new anthrax vaccines is to protect humans against the intentional use of Bacillus anthracis as a bioterrorist or warfare agent. Live attenuated vaccines against anthrax in domesticated animals were among the very first vaccines developed. This was followed by the development of nonliving component vaccines leading to the eventual licensure of protein-based vaccines for human use in the 1970s. This chapter will review the recent advances in developing protein, live attenuated, and genetic vaccines against anthrax.

Citing Articles

Genome Sequence and Phenotypic Analysis of a Protein Lysis-Negative, Attenuated Anthrax Vaccine Strain.

Yuan L, Wang D, Chen J, Lyu Y, Feng E, Zhang Y Biology (Basel). 2023; 12(5).

PMID: 37237459 PMC: 10215202. DOI: 10.3390/biology12050645.


Comparative Analysis of the Global Transcriptomic Response to Oxidative Stress of -Disrupted and Parental Wild Type Strains.

Zaide G, Elia U, Cohen-Gihon I, Israeli M, Rotem S, Israeli O Microorganisms. 2020; 8(12).

PMID: 33265965 PMC: 7760947. DOI: 10.3390/microorganisms8121896.


The Group: Species with Pathogenic Potential.

Ehling-Schulz M, Lereclus D, Koehler T Microbiol Spectr. 2019; 7(3).

PMID: 31111815 PMC: 6530592. DOI: 10.1128/microbiolspec.GPP3-0032-2018.


A Bivalent Protein r-PAbxpB Comprising PA Domain IV and Exosporium Protein BxpB Confers Protection Against Spores and Toxin.

Majumder S, Das S, Somani V, Makam S, Kingston J, Bhatnagar R Front Immunol. 2019; 10:498.

PMID: 30941133 PMC: 6433990. DOI: 10.3389/fimmu.2019.00498.


Bioinspired detoxification of blood: The efficient removal of anthrax toxin protective antigen using an extracorporeal macroporous adsorbent device.

Ingavle G, Baillie L, Davies N, Beaton N, Zheng Y, Mikhalovsky S Sci Rep. 2018; 8(1):7518.

PMID: 29760471 PMC: 5951949. DOI: 10.1038/s41598-018-25678-0.